DSE:RELIANCINS

Reliance Insurance PLC. announcements

290 Dhaka Stock Exchange announcements for Reliance Insurance PLC. (RELIANCINS) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (17).

  1. Q3 Financials

    (Q3 Un-audited): EPS was Tk. 2.57 for July-September 2025 as against Tk. 2.30 for July-September 2024; EPS was Tk. 7.96 for January-September 2025 as against Tk. 6.93 for January-September 2024. NOCFPS was Tk. 8.70 for January-September 2025 as against Tk. 5.68 for January-September 2024. NAV per share was Tk. 76.62 as on September 30, 2025 and Tk. 69.59 as on December 31, 2024.

  2. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 29, 2025 at 2:45 PM to consider, among others, Un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2025.

  3. Name Change of the Company

    Dhaka Stock Exchange PLC. (DSE) has approved the proposed name change of the Company. Accordingly, the name of the Company will be 'Reliance Insurance PLC.' instead of 'Reliance Insurance Limited' with effect from September 28, 2025. Other information (except name) will remain unchanged.

  4. Q2 Financials

    (Q2 Un-audited): EPS was Tk. 3.12 for April-June 2025 as against Tk. 2.67 for April-June 2024; EPS was Tk. 5.39 for January-June 2025 as against Tk. 4.63 for January-June 2024. NOCFPS was Tk. 16.74 for January-June 2025 as against Tk. 10.31 for January-June 2024. NAV per share was Tk. 71.00 as on June 30, 2025 and Tk. 69.59 as on December 31, 2024. Reasons for deviation in EPS, NOCFPS and NAVPS: EPS has increased due to increase of premium income and investment income. (cont.) (Cont. News of RELIANCINS): NOCFPS has increased due to increase in premium collection and related reinsurance payment will be made gradually in the next quarter. NAVPS has increased mainly due to increase in retained earnings. (end)

  5. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 29, 2025 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2025.

  6. Credit Rating Result

    Credit Rating Information and Services Limited (CRISL) has assigned the rating of the Company as "AAA" in the long term along with Stable outlook in consideration of its audited financials up to December 31, 2024; unaudited financials up to March 31, 2025 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

  7. Q1 Financials

    (Q1 Un-audited): EPS was Tk. 2.27 for January-March 2025 as against Tk. 1.96 for January-March 2024. NOCFPS was Tk. 7.84 for January-March 2025 as against Tk. 2.41 for January-March 2024. NAV per share was Tk. 68.61 as on March 31, 2025 and Tk. 69.59 as on December 31, 2024. (cont.) (Cont. News of RELIANCINS): Reasons for deviation: Earnings per share increased due to increase of premium income and investment income. NOCFPS increased mainly due to decrease of reinsurance premium payment. NAV per share decreased due to decrease in fair value of shares. (end)

  8. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 14, 2025 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2025.

  9. Dividend Disbursement

    The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2024 to the respective shareholders.

  10. Resumption after Record date

    Trading of the shares of the company will resume on 04.03.2025.

  11. Suspension for record date

    Trading of the shares of the company will remain suspended on record date i.e., 03.03.2025.

  12. Spot News

    Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 27.02.2025 to 02.03.2025 and trading of the shares will remain suspended on record date i.e., 03.03.2025.

  13. Dividend Declaration

    The Board of Directors of the company has recommended 30% Cash Dividend for the year ended December 31, 2024. The Company has reported EPS of Tk. 9.12, NAV per share of Tk. 69.59 and NOCFPS of Tk. 1.66 for the year ended December 31, 2024 as against Tk. 6.56, Tk. 66.85 and Tk. 4.84 respectively for the year ended December 31, 2023. Date of AGM: 25.03.2025. Record Date: 03.03.2025. Venue of AGM: Virtually using Digital Platform. Time: 11:00 AM. (cont.) (cont. news of RELIANCINS): Reasons for deviation in EPS, NOCFPS and NAV per share: EPS increased mainly due to increase in premium and investment income. NOCFPS decreased due to increase in reinsurance payment. NAV per share increased due to increase in retained earnings. (end)

  14. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (11.02.2025) following its corporate declaration.

  15. Update of Information

    The company has informed that the shareholders whose names would appear in the Register of Members of the Company on the Record date shall be entitled to dividend and attend the 37th Annual General Meeting (AGM). The Company has requested the shareholders to update their e-mail addresses through their respective Depository Participant (DP). (cont.) (Cont. news of RELIANCINS): The Company will forward the Annual Report 2024 in soft form to the e-mail addresses of the Shareholders available in their beneficial owner (BO) accounts maintained with the Depository. The Company has also requested the shareholders to update their respective BO account with 12 digits e-TIN, BO account address. mobile number etc. through their respective DPs before the Record Date. (end)

  16. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 10, 2025 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.

  17. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 10, 2025 at 2:45 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2024. Please disreagrd the previous news disseminated today i.e., 02.02.2025 regarding board meeting schedule under LR 16(1).

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.